In The News
High Court cases could push Blue Sky class action trial to 2026
Google faces potential class action over AdTech dominance
Court approves landmark $75M detention centre class action settlement
Dominique Grubisa’s companies illegally scraped court websites: OAIC
Burger ad beef between McDonald’s, Hungry Jack’s done
Class action probe accuses union of forcing staff to join Labor Party
Collapsed Mosaic Brands owes creditors over $245M
Travelex wins opposition to blockchain tech company’s trade marks
Bubble tea chain Chatime fined for underpaying staff
Class action firm breaches costs disclosure rules again, fights penalty
Please login to bookmarkClose

A unit of Purdue Pharma has fired off a cross-claim in Australian drug maker AUPharma’s lawsuit alleging the US drug giant was wrongly granted patent extensions for oxycodone products marketed as Targin.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au